New research shows luspatercept enables majority of patients with MDS to end reliance on blood transfusions
Treatment with luspatercept improved red blood cell counts and erythroid responses compared to treatment with epoetin alfa in patients with myelodysplastic syndromes (MDS), allowing the majority to no longer require regular ...
May 25, 2023
0
2